PAR-22-216 - NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer NOT-CA-22-085 NCI May 5, 2022 Jul 5, 2027 K22, R01, K08, K01, R21, R03, K99/R00
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity NOT-CA-22-001 NCI , NHLBI Nov 4, 2021 Nov 6, 2024 R01, R03, R21, P01
Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention NOT-CA-21-121 NCI Oct 4, 2021 Sep 8, 2024 K22, K08, R15, R01, R21, K99/R00,
Notice of Special Interest (NOSI): Advancing the development of tumor site-activated small molecules NOT-CA-21-101 NCI Aug 16, 2021 Jan 8, 2024 R01, R15, R21

Expired NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)


Technical Issues: E-mail OER Webmaster